NCT03120481

Brief Summary

This is the registry of control participants for patients with various respiratory diseases. We screened healthy volunteers who visited Seoul National Hospital Healthcare System Gangnam Center for routine health check-up, and enrolled patients who agree to participate in the study. The participants undergo baseline questionnaires, provide blood specimen and information of the results of health check-up. We will include participants as controls if they have no significant respiratory symptom and no significant radiographic abnormality. The data from this registry will be compared with those from other registry of various respiratory diseases

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,572

participants targeted

Target at P75+ for all trials

Timeline
132mo left

Started Apr 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Apr 2017Feb 2037

Study Start

First participant enrolled

April 10, 2017

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

April 14, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 19, 2017

Completed
19.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2037

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2037

Last Updated

April 19, 2017

Status Verified

April 1, 2017

Enrollment Period

19.9 years

First QC Date

April 14, 2017

Last Update Submit

April 14, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mortality

    Death

    20 years

Secondary Outcomes (3)

  • Hospitalization

    20 years

  • Respiratory hospitalization

    20 years

  • Respiratory diseases diagnosis

    20 years

Study Arms (1)

Normal control

Other: no intervation

Interventions

no intervention

Normal control

Eligibility Criteria

Age19 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Those who visited the hospital for health check-up, and agree to participate in this study.

You may qualify if:

  • years old male and female
  • underwent health check-up including chest radiography
  • obtained informed consent

You may not qualify if:

  • those who showed a significant abnormal finding of chest radiography
  • those who reported a significant respiratory symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Healthcare System Gangnam Center

Seoul, Seoul, 06236, South Korea

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

DNA Plasma Serum

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveAsthmaIdiopathic Pulmonary FibrosisMycobacterium Infections, NontuberculousBronchiectasisLung Neoplasms

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBronchial DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesPulmonary FibrosisLung Diseases, InterstitialMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasms

Study Officials

  • Chang-Hoon Lee, M.D.

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chang-Hoon Lee, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
20 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

April 14, 2017

First Posted

April 19, 2017

Study Start

April 10, 2017

Primary Completion (Estimated)

February 28, 2037

Study Completion (Estimated)

February 28, 2037

Last Updated

April 19, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations